These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16974202)

  • 21. Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.
    Reilly-Harrington NA; Deckersbach T; Knauz R; Wu Y; Tran T; Eidelman P; Lund HG; Sachs G; Nierenberg AA
    J Psychiatr Pract; 2007 Sep; 13(5):291-7. PubMed ID: 17890977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.
    Faulkner MA; Burke RA
    Expert Opin Drug Saf; 2013 Nov; 12(6):847-55. PubMed ID: 23883095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.
    Sander SE; Lemm C; Lange N; Hamann M; Richter A
    Neuropharmacology; 2012 Feb; 62(2):1052-61. PubMed ID: 22079161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retigabine: blue skin discoloration and retinal pigment abnormalities.
    Prescrire Int; 2013 Nov; 22(143):269. PubMed ID: 24427841
    [No Abstract]   [Full Text] [Related]  

  • 25. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
    Kanba S; Yagi G; Kamijima K; Suzuki T; Tajima O; Otaki J; Arata E; Koshikawa H; Nibuya M; Kinoshita N
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):707-15. PubMed ID: 7938561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divalproex extended-release in acute bipolar II depression.
    Wang PW; Nowakowska C; Chandler RA; Hill SJ; Nam JY; Culver JL; Keller KL; Ketter TA
    J Affect Disord; 2010 Jul; 124(1-2):170-3. PubMed ID: 19923006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Keck PE; Hsu HA; Papadakis K; Russo J
    Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticonvulsants in bipolar disorder.
    Singh V; Muzina DJ; Calabrese JR
    Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comment on Craig et al.: ''Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization: a NICE single technology appraisal''.
    Holko P; Kawalec P
    Pharmacoeconomics; 2013 Jun; 31(6):533-5. PubMed ID: 23539279
    [No Abstract]   [Full Text] [Related]  

  • 32. Ezogabine (retigabine).
    Stafstrom CE; Grippon S; Kirkpatrick P
    Nat Rev Drug Discov; 2011 Sep; 10(10):729-30. PubMed ID: 21959281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder.
    Kulkarni J; Garland KA; Scaffidi A; Headey B; Anderson R; de Castella A; Fitzgerald P; Davis SR
    Psychoneuroendocrinology; 2006 May; 31(4):543-7. PubMed ID: 16356651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent and future antiepileptic drugs and their impact on cognition: what can we expect?
    Mula M
    Expert Rev Neurother; 2012 Jun; 12(6):667-71. PubMed ID: 22650169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of agitation in bipolar disorder across the life cycle.
    Alderfer BS; Allen MH
    J Clin Psychiatry; 2003; 64 Suppl 4():3-9. PubMed ID: 12672259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant levetiracetam in adolescent mania.
    Desarkar P; Das B; Sinha VK
    J Clin Psychopharmacol; 2007 Apr; 27(2):215-6. PubMed ID: 17414251
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
    Brady KT; Sonne SC; Anton R; Ballenger JC
    J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clobazam, ezogabine, and tafluprost.
    Hussar DA; Hallinan SE
    J Am Pharm Assoc (2003); 2012; 52(4):546-50. PubMed ID: 22825237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.